Related Experiment Video

Updated: Jun 4, 2026

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

New players in ovarian cancer

Alessandro Bovicelli1, Giuseppina D'Andrilli, Antonio Giordano

  • 1Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

Journal of Cellular Physiology
|February 9, 2011
PubMed

Insights

This review explores ovarian cancer (OC) pathogenesis, focusing on cell cycle genes, transcription factors, and microRNAs. It highlights new therapeutic strategies, including histone deacetylase inhibitors, and chemoresistance mechanisms to improve OC diagnosis and treatment.

Area of Science:

  • Gynecologic Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Ovarian cancer (OC) is the leading cause of gynecologic cancer mortality globally.
  • Understanding OC pathogenesis is crucial for developing effective treatments.
  • Chemoresistance remains a significant challenge in managing OC.

Purpose of the Study:

  • To review recent studies on ovarian cancer pathogenesis.
  • To highlight novel therapeutic approaches for OC.
  • To discuss the role of specific genes, microRNAs, and histone deacetylase inhibitors in OC.

Main Methods:

  • Literature review of recent studies on ovarian cancer.
  • Analysis of cell cycle genes, transcription factors, and microRNAs in carcinogenesis.
  • Evaluation of histone deacetylase inhibitors as a therapeutic hypothesis.
  • Review of mechanisms contributing to chemoresistance in OC.

Main Results:

  • Recent studies implicate cell cycle genes, transcription factors, and microRNAs in OC development.
  • Histone deacetylase inhibitors present a promising new therapeutic avenue.
  • Understanding chemoresistance mechanisms is vital for treatment efficacy.
  • Advances in knowledge can improve OC diagnosis and patient outcomes.

Conclusions:

  • Recent research offers insights into OC tumorigenesis and potential therapeutic targets.
  • Novel strategies, including epigenetic modifiers, show promise against OC.
  • Addressing chemoresistance is key to improving survival rates for ovarian cancer patients.

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of cuboidal...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...